Stocks
Tevogen Inc.TVGN
NASDAQHealthcareBiotechnology$6.53
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing off-the-shelf, allogeneic T-cell therapies for infectious diseases and cancers. Its lead candidate targets COVID-19 and other viral infections, with a focus on providing rapid, scalable treatment options. Investors track the stock for its potential in the emerging allogeneic cell therapy space.
52W Range: $3.64-$33.30
Congressional Interest in Tevogen Inc. (TVGN)
No congressional trades have been disclosed for Tevogen Inc. (TVGN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading TVGN?
No congressional trades found for this stock.